Pulsenmore Ltd., a pioneer in home ultrasound technology, has partnered with Ouma Health, the largest independent virtual maternity care provider in the United States. This collaboration will integrate Pulsenmore's FDA-approved home ultrasound system into Ouma Health's extensive telemedicine platform. The initiative is set to enhance prenatal monitoring by bringing critical diagnostic capabilities directly into patients' homes.
A Strategic Alliance for Modern Maternity Care
Through this agreement, Ouma Health will offer patients access to Pulsenmore's innovative home ultrasound solution. The technology enables pregnant women to conduct self-scans while connected to their clinical teams for guidance and review. This integration seeks to create a more seamless and supportive virtual care experience throughout a patient's pregnancy.
For Pulsenmore, this partnership represents a significant expansion of its presence within the U.S. maternal healthcare market. By aligning with Ouma Health's established network, the company can deploy its technology through a trusted virtual care pathway. The move capitalizes on the growing demand for patient-centered solutions that extend healthcare beyond traditional clinics.
Addressing Critical Gaps in Prenatal Access
A key driver for this collaboration is the need to address disparities in maternal healthcare access across the country. With 35% of U.S. counties designated as maternal care deserts, many expectant mothers face considerable geographic and logistical hurdles. This partnership provides a tangible solution to bridge these gaps by reducing reliance on in-person clinic visits.
Dr. Sina Haeri, CEO of Ouma Health, noted the technology empowers his team to better serve these vulnerable populations. Similarly, Pulsenmore's CEO, Dr. Elazar Sonnenschein, highlighted the opportunity to embed ultrasound into virtual care to expand monitoring. Both leaders emphasized the goal of keeping patients at the center of their care regardless of their location.
The Technological and Clinical Impact
The integration of Pulsenmore's technology makes Ouma Health's virtual maternity services more clinically complete. It allows providers to gather essential diagnostic information remotely, which was previously only possible during in-person appointments. This capability enhances care continuity and allows for more timely interventions when necessary.
This alliance exemplifies the future of prenatal care, blending advanced telemedicine with home-based medical devices. It creates a scalable model that can be adopted by healthcare systems and insurance organizations. The partnership is poised to set a new standard for hybrid maternity care delivery in the United States.
Company Profiles and Market Position
Ouma Health is the nation's largest independent provider of maternity telemedicine, with a network spanning all 50 states. Founded by maternal-fetal medicine specialists, the company partners with insurers and health systems to improve outcomes. Its platform offers comprehensive support from pre-conception through the postpartum period.
Based in Israel, Pulsenmore is a publicly traded company on both the NASDAQ and Tel Aviv Stock Exchange. The company has demonstrated impressive year-over-year revenue growth, reaching $12.6 million in the last twelve months. Despite this rapid expansion, the firm remains in a growth phase and is not yet profitable.
The partnership between Pulsenmore and Ouma Health marks a pivotal advancement in maternal healthcare delivery. By combining state-of-the-art home ultrasound technology with a leading virtual care platform, the initiative directly confronts access barriers. This collaboration is set to improve the pregnancy experience and health outcomes for women, especially those in underserved communities.